What Sysmed does

SysMed is a privately held French home healthcare provider (PSAD - Prestataire de Santé à Domicile) founded in 2002 and headquartered in Templemars, operating across the Hauts-de-France region through three regional entities: SysMed Assistance (HQ), SysMed Pas-de-Calais (Loos-en-Gohelle, opened 2012), and SysMed Avesnois (Maubeuge, opened 2018). The company delivers complex respiratory therapies to patients at home on medical prescription, including oxygen therapy (long-term and short-term oxygen via concentrators), aerosol therapy, non-invasive ventilation (VNI), continuous positive airway pressure (CPAP/PPC) treatment for sleep apnea, and tracheotomy care. Service delivery relies on qualified medical-technical interveners who install equipment, train patients and caregivers, perform scheduled follow-up visits (every 2-4 months for ventilation patients), provide 24/7 technical support with repair/replacement commitments within 12 hours for VNI patients, and coordinate ongoing medical follow-up.

The company's technology stack is centered on certified home respiratory medical devices (oxygen concentrators, CPAP/PPC machines, ventilators, nebulizers, tracheotomy equipment) supplemented by a telemonitoring platform that transmits patient device data to prescribing physicians and the My SysMed mobile application (available on iOS and Android) which provides appointment reminders, treatment data visualization, and direct messaging with the care team. Dedicated patient and physician web portals (Sysmedweb.fr) support account management and treatment follow-up. The company is CNIL-compliant for data protection and signatory to the Charter for Home Healthcare Patients, reflecting operating constraints typical of the regulated French PSAD sector.

SysMed operates a managed-services revenue model under the French national health insurance system (CPAM - Caisse Primaire d'Assurance Maladie), with services reimbursed on a prescription basis at fixed nomenclature tariffs. The go-to-market is sales-led via medical prescription referrals — physicians and healthcare institutions prescribe home respiratory therapies, and SysMed executes delivery through its technician network. Customer segments are two-sided: individual patients with chronic respiratory conditions (COPD, sleep apnea, neuromuscular disease, post-tracheotomy) and the prescribing healthcare professionals who coordinate care. Headcount is in the 11-50 range based on disclosed firmographics and historical growth from 3 employees at founding in 2002 to dozens of qualified positions created across regional expansions by 2012 onward. No external investors, funding rounds, or M&A activity are disclosed. Johan Bacquet is identified as Director of Publication for the group.

Name

Sysmed

Legal name

Sysmed Assistance, Sysmed Avesnois, Sysmed Pas-De-Calais

Website

https://sysmed.fr

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

11–50 employees

Short description

SysMed is a privately held French home healthcare provider founded in 2002, operating three regional agencies across Hauts-de-France to deliver prescribed respiratory therapies — oxygen therapy, aerosol therapy, non-invasive ventilation, sleep apnea treatment, and tracheotomy care — directly to patients in their homes under French national health insurance reimbursement.

Ownership category

akta.pro rank

Product category

Home Healthcare Services

NAICS

Home Health Care Services (62161)

SIC

Services-Home Health Care Services (8082)

akta.pro primary industry

Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management (HLAKANAM)

akta.pro secondary industries

Hospital-at-Home / Acute Care at Home Programs (HLAFAEAH), Cardiac & Pulmonary Clinical Home Health (e.g., CHF/COPD) (HSABACAI)

Keywords

• Home healthcare services
• Respiratory therapy
• Oxygen therapy
• Sleep apnea treatment
• Ventilation therapy

Headquarters

HQ city

Templemars

HQ country

France

HQ region

Europe

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Home Healthcare Services Reimbursement: SysMed operates as a home healthcare provider under the French social security system (CPAM - Caisse Primaire d'Assurance Maladie). Services are covered through medical prescriptions, with reimbursement handled through the French national health insurance system. The company manages administrative procedures, prescription coordination, and patient follow-up as part of its service delivery.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Sysmed is a regional home healthcare provider that delivers specialized respiratory medical treatments directly to patients' homes in the Hauts-de-France region of France. Services are initiated on medical prescription and include oxygen therapy, aerosol therapy, non-invasive ventilation, sleep apnea (CPAP/PPC) treatment, and tracheotomy care, with equipment installation, patient training, follow-up visits, maintenance, and 24/7 technical support provided by qualified medical-technical staff.

Product overview

Sysmed is a regional home healthcare provider operating across the Hauts-de-France region of France, offering a unified portfolio of five core respiratory care services: Oxygen Therapy (Oxygénothérapie), Aerosol Therapy (Aérosolthérapie), Non-Invasive Ventilation (VNI), Sleep Apnea treatment (PPC), and Tracheotomy care. These services are coordinated through multiple operational entities (SysMed Assistance, SysMed Pas-de-Calais, SysMed Avesnois) and supported by the My SysMed mobile application and patient/physician web portals for remote monitoring and communication.

Differentiator

Problem solved

Functional benefit

Brands

• My SysMed: Mobile application for patients to manage their respiratory treatment, receive appointment reminders, consult treatment data, and communicate with the SysMed team.

Products and services

• Oxygen Therapy (Oxygénothérapie) Long-term oxygen therapy (OLD) and short-term oxygen therapy for chronic severe respiratory insufficiency, including portable concentrator services for mobile patients. Delivered at home on medical prescription.
• Aerosol Therapy (Aérosolthérapie) Medication delivery via nebulizer for respiratory conditions including asthma, chronic bronchitis, cystic fibrosis, and pulmonary infections, administered at home on medical prescription.
• Non-Invasive Ventilation (Ventilation Non Invasive / VNI) Ventilator-based treatment with mask interface for patients whose lungs cannot maintain adequate gas exchange, indicated for neuromuscular diseases and severe obesity with respiratory disorders. Includes technical visits every 2-4 months and equipment repair/replacement within 12 hours.
• Sleep Apnea Treatment (Apnée du sommeil / PPC-CPAP) Continuous Positive Airway Pressure (CPAP/PPC) therapy for sleep apnea, including device installation, monitoring, and patient follow-up at home on medical prescription.
• Tracheotomy Care (Trachéotomie) Home care for tracheostomy patients including equipment installation, cannula maintenance, suction procedures, and 24/7 assistance, delivered on medical prescription.

Quantifiable outcome

• Treatment equipment repaired or replaced within 12 hours for non-invasive ventilation patients
• +1 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators4 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• SOS Oxygène: Independent French home oxygen and respiratory care provider operating multiple regional agencies. Closely comparable to Sysmed in scope (oxygen therapy, ventilation, sleep apnea), target patients, and prescriber-led GTM motion.
• Asten Santé: National French home healthcare provider covering respiratory, perfusion, nutrition, and diabetes care. Comparable to Sysmed in respiratory home services but with broader service mix and multi-region presence.
• ADIR Assistance: French home healthcare provider focused on respiratory treatments, infusion, and medical-technical interventions. Operates in northern France and overlaps directly with Sysmed's patient segments and clinical service lines.
• Orkyn': French home healthcare provider (part of Air Liquide) delivering oxygen therapy, ventilation, sleep apnea treatment, and infusion/nutrition services. Direct competitor with overlapping respiratory portfolio and similar reimbursement model through CPAM.

Broad incumbents

• VitalAire (Air Liquide Healthcare): The leading French home respiratory care provider (subsidiary of Air Liquide) covering oxygen therapy, ventilation, sleep apnea, and tracheostomy nationally. Comparable to Sysmed on every service line but operates at national scale with a much larger prescriber and hospital network.
• Linde Healthcare: Home respiratory care arm of Linde, a global industrial gas major. Provides oxygen therapy, sleep apnea, and ventilation services in France with national infrastructure — comparable service lines to Sysmed at much larger corporate scale.

Others

• Philips Respironics: Major manufacturer of sleep apnea and home ventilation equipment used by Sysmed. Comparable ecosystem overlap (same patient categories and clinical indications), though Philips is a device vendor rather than a home-care service competitor.
• ResMed: Global leader in sleep apnea and respiratory care devices (CPAP, ventilators). Adjacent rather than direct: ResMed supplies equipment to providers like Sysmed but does not deliver home-care services in France.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/sysmedassistance
• LinkedInlinkedin.com/company/sysmed-assistance

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sysmed